Signaturefd LLC Buys 1,052 Shares of Fresenius Medical Care AG (NYSE:FMS)

Signaturefd LLC raised its stake in Fresenius Medical Care AG (NYSE:FMS) by 16.6% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 7,393 shares of the company’s stock after buying an additional 1,052 shares during the quarter. Signaturefd LLC’s holdings in Fresenius Medical Care were worth $167,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently bought and sold shares of FMS. Smartleaf Asset Management LLC lifted its stake in Fresenius Medical Care by 192.8% in the fourth quarter. Smartleaf Asset Management LLC now owns 1,224 shares of the company’s stock valued at $28,000 after buying an additional 806 shares in the last quarter. Wilmington Savings Fund Society FSB bought a new stake in shares of Fresenius Medical Care in the third quarter worth $38,000. Jones Financial Companies Lllp lifted its position in shares of Fresenius Medical Care by 80.5% in the fourth quarter. Jones Financial Companies Lllp now owns 4,510 shares of the company’s stock worth $102,000 after purchasing an additional 2,012 shares in the last quarter. Venturi Wealth Management LLC lifted its position in shares of Fresenius Medical Care by 8.4% in the fourth quarter. Venturi Wealth Management LLC now owns 5,700 shares of the company’s stock worth $129,000 after purchasing an additional 441 shares in the last quarter. Finally, GAMMA Investing LLC lifted its position in shares of Fresenius Medical Care by 43.3% in the fourth quarter. GAMMA Investing LLC now owns 7,164 shares of the company’s stock worth $162,000 after purchasing an additional 2,166 shares in the last quarter. Institutional investors own 8.37% of the company’s stock.

Fresenius Medical Care Stock Performance

NYSE FMS opened at $24.29 on Friday. The company has a current ratio of 1.37, a quick ratio of 1.02 and a debt-to-equity ratio of 0.42. The firm’s fifty day moving average price is $23.86 and its two-hundred day moving average price is $22.37. Fresenius Medical Care AG has a 1 year low of $17.93 and a 1 year high of $25.25. The firm has a market capitalization of $14.25 billion, a P/E ratio of 20.07, a price-to-earnings-growth ratio of 0.76 and a beta of 0.99.

Analyst Ratings Changes

A number of analysts have recently commented on the stock. Bank of America raised shares of Fresenius Medical Care from an “underperform” rating to a “neutral” rating in a research report on Monday, December 2nd. Truist Financial boosted their price objective on shares of Fresenius Medical Care from $23.00 to $25.00 and gave the stock a “hold” rating in a research report on Monday, January 6th. Finally, StockNews.com raised shares of Fresenius Medical Care from a “hold” rating to a “strong-buy” rating in a research report on Wednesday, February 5th.

About Fresenius Medical Care

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.